Cargando…
Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy
In the last few decades, RNA-based drugs have emerged as a promising candidate in the treatment of various diseases. The introduction of messenger RNA (mRNA) as a vaccine or therapeutic agent enables the production of almost any functional protein/peptide. The key to applying RNA therapy in clinical...
Autores principales: | Shim, Kyeonghee, Jo, Hyein, Jeoung, Dooil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572814/ https://www.ncbi.nlm.nih.gov/pubmed/37834126 http://dx.doi.org/10.3390/ijms241914679 |
Ejemplares similares
-
The Potential of Senescence as a Target for Developing Anticancer Therapy
por: Jo, Hyein, et al.
Publicado: (2023) -
Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
por: Jo, Hyein, et al.
Publicado: (2023) -
Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance
por: Jo, Hyein, et al.
Publicado: (2022) -
Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics
por: Jo, Hyein, et al.
Publicado: (2022) -
Exosomes: Diagnostic and Therapeutic Implications in Cancer
por: Jo, Hyein, et al.
Publicado: (2023)